External defibrillators market analysis report by Future Market Insights shows that global sales in 2021 were held at US$ 3 Billion. With 10.4%, the projected market growth from 2022 to 2032 is expected to be significantly higher than the historical growth. The growing incidence of cardiac disorders such as arrhythmias and bradycardias, among others, the rise in the geriatric population, integration of advanced technology, growing investments by government and private manufacturers, and rising awareness programs regarding cardiovascular disorders contribute to an increase in the use of external defibrillators, consequently driving the market. Manual External Defibrillators are expected to be the highest revenue-generating application, with a CAGR of around 11.4% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global External Defibrillators Market (2022) | US$ 3.3 Billion |
| Global External Defibrillators Market (2032) | US$ 8.8 Billion |
| Global External Defibrillators Market CAGR (2022 to 2032) | 10.4% |
| North America External Defibrillators Market | 11.2% |
| USA External Defibrillators Market (2022) | US$ 1.2 Billion |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the External Defibrillator research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of external defibrillators increased at around 8.6% CAGR, wherein, countries such as the USA, China, and Japan held a significant share in the global market.
The constant surge in urbanization has also aggravated healthcare needs across several countries. Owing to this, the demand for an external defibrillator is projected to grow at a CAGR of 10.4% over the coming 10 years.
In the elderly population and individuals suffering from chronic conditions such as high blood pressure, obesity, and heart disorders, atrial fibrillation, which is characterized by an irregular and most often rapid heart rate, can raise the risk of stroke, heart failure, and other heart-related complications. According to a study released in NCBI 2021, atrial fibrillation is perhaps the most common cardiac arrhythmia, with a global prevalence of 37.5 billion people diagnosed in 2017. Furthermore, according to the WHO report for 2021, heart disease and stroke account for 85% of all cardiovascular fatalities.
Defibrillators are devices that provide an electric shock to restore a regular heartbeat. They are used to treat or prevent arrhythmias. Furthermore, the launch of numerous new defibrillators with easier insertion technology, smaller size, and fewer or no leads placed in the heart is expected to propel the external defibrillators market growth. Biotronik, for example, introduced the Acticor gadget series of innovative ICDs and cardiac resynchronization therapy defibrillators (CRT-Ds) in 2019. The hybrid ICD Acticor devices provide dual-chamber diagnostics without the use of an atrial lead.
The rising prevalence of hypertension among the global population, as well as an increase in cardiovascular illnesses such as arrhythmias and bradycardias, will boost the external defibrillators market. In addition to an aging population, people who are more likely to have heart-related disorders are expected to boost the external defibrillators market. Furthermore, rising healthcare expenditures, improved healthcare infrastructure, technical improvements, and an increase in disposable income in developing nations are all factors that are expected to enhance the market. Furthermore, the increasing push of several governments to install external defibrillators in public locations other than hospitals in order to prevent sudden cardiac death is a major driver driving the growth of the external defibrillators market.
Rapid technical advancements, as well as favorable government regulation, are expected to propel the External Defibrillators market over the forecast period.
AEDs (automated external defibrillators) are life-saving devices that assist in cardiac rhythm correction. The rising prevalence of cardiac disorders, the expanding elderly population, and technical developments in the industry, supported by increased investment by market participants, are the key factors propelling the market.
Principal Consultant
During the projected period, North America is expected to dominate the external defibrillators market. In 2021, North America had the highest revenue share, accounting for more than 35%. This dominance can be attributed to the rising prevalence of cardiovascular disorders, improved healthcare infrastructure, and the presence of significant external defibrillator market participants in the region. Furthermore, the risks of developing cardiovascular disease are skyrocketing in the United States. The presence of key manufacturers in the region, such as Stryker, ZOLL, and Phillips, among others, would also boost the market for external defibrillators.
In 2021, Boston Scientific, for example, reported that it had distributed around 33,000 CRT-Ds devices worldwide, including Ring true, Autogen, Dynagen, Incepta, and Cognis. There were 16,500 registered devices in the United States alone, indicating a significant adoption rate.
The market for external defibrillator treatments in North America is also rising due to the region's growing geriatric population and high consumer awareness. Furthermore, the presence of market competitors and increasing demands for modern medical systems in the area contribute to the region's leading market position.
Due to improvements in research infrastructure, an increase in the geriatric population, and a high prevalence of cardiovascular illnesses, the European market is projected to swell. Furthermore, Asia Pacific held a significant share and is expected to be the fastest-growing regional market, owing to an increased incidence of heart attacks, and the presence of a large patient pool suffering from cardiovascular diseases; especially in emerging economies such as Hong Kong and Singapore. The improvement of technology in these countries has created a profitable opportunity for the worldwide defibrillator market to flourish. During the projection period, the market in Latin America and the Middle East, and Africa is expected to rise at a slower pace.
With an over 11.5% projected growth rate, external defibrillators market revenue is expected to grow at the fastest pace in the USA, from 2022 to 2032. The market in the USA is predicted to grow due to the presence of a well-developed healthcare infrastructure, which is also rising due to the region's growing geriatric population and high consumer awareness. Furthermore, the presence of established market competitors and increasing demand for modern medical systems in the area contribute to the region's leading market position.
The external defibrillators market in the United Kingdom is expected to reach a valuation of 326 Million by 2032, at a CAGR of 10%. The market growth from 2017 to 2021 was observed at 8.5%.
The Japanese external defibrillator market is expected to witness an absolute dollar growth of US$ 260 Million, growing at a CAGR of 10.3% from 2022 to 2032. The market is projected to reach a valuation of US$ 416.5 Million by 2032.
The external defibrillators market in South Korea is projected to account for an absolute dollar opportunity of US$ 99 Million. By 2032, it will reach a valuation of US$ 156.5 Million growing at a CAGR of 10.5%.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
During the projection period, manual external defibrillators are anticipated to lead the market. The rising frequency of cardiovascular disorders and the introduction of technologically improved defibrillators are responsible for the considerable share of manual external defibrillators. Besides, manual external defibrillators are also cost-effective, which is the key factor for their high share.
Some of the key companies operating in the external defibrillators market include Medtronic, Stryker Corporation, Koninklijke Philips N.V., Asahi Kasei Corporation, Boston Scientific Corporation, Abbott, Nihon Kohden, MicroPort, BIOTRONIK, CU Medical Systems, METsis Medikal, Mediana Co. Ltd., and Mindray Medical International.
Some of the recent developments by key external defibrillator providers are as follows:
Similarly, the Future Market Insights team has been keeping track of recent advancements in the field of external defibrillators, which are detailed in the complete research.
The External defibrillators market is worth more than US$ 3 Billion at present.
The value of external defibrillators is projected to increase at a CAGR of around 10.4% from 2022 to 2032.
The value of External Defibrillators increased at a CAGR of around 8.6% from 2017 to 2021.
Factors responsible for the growth of the External defibrillators market include the growing demand for health solutions.
The top 5 countries driving the demand for external defibrillators are the USA, United Kingdom, China, Japan, and South Korea
The market in North America is expected to grow at the highest CAGR of around 11.2%.
1. Executive Summary | External Defibrillators Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2022 to 2032
5.3.1. Manual External Defibrillators
5.3.2. Automated External Defibrillators
5.3.2.1. Semi-Automated ED
5.3.2.2. Fully Automated ED
5.3.3. Wearable Cardioverter Defibrillators
5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Product, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2022 to 2032
6.3.1. Hospital
6.3.2. Pre Hospital
6.3.3. Public Access Market
6.3.4. Alternate Care Market
6.3.5. Home Healthcare
6.4. Y-o-Y Growth Trend Analysis By End-use, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By End-use, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa(MEA)
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product
8.2.3. By End-use
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product
8.3.3. By End-use
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product
9.2.3. By End-use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By End-use
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Product
10.2.3. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By End-use
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. India
11.2.1.5. Malaysia
11.2.1.6. Singapore
11.2.1.7. Australia
11.2.1.8. New Zealand
11.2.1.9. Rest of APAC
11.2.2. By Product
11.2.3. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By End-use
11.4. Key Takeaways
12. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of Middle East and Africa(MEA)
12.2.2. By Product
12.2.3. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By End-use
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Product
13.1.2.2. By End-use
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Product
13.2.2.2. By End-use
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Product
13.3.2.2. By End-use
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Product
13.4.2.2. By End-use
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Product
13.5.2.2. By End-use
13.6. United Kingdom
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Product
13.6.2.2. By End-use
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Product
13.7.2.2. By End-use
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Product
13.8.2.2. By End-use
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Product
13.9.2.2. By End-use
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Product
13.10.2.2. By End-use
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Product
13.11.2.2. By End-use
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Product
13.12.2.2. By End-use
13.13. Malaysia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Product
13.13.2.2. By End-use
13.14. Singapore
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Product
13.14.2.2. By End-use
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Product
13.15.2.2. By End-use
13.16. New Zealand
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Product
13.16.2.2. By End-use
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Product
13.17.2.2. By End-use
13.18. South Africa
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Product
13.18.2.2. By End-use
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Product
13.19.2.2. By End-use
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product
14.3.3. By End-use
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Koninklijke Philips N.V.
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Stryker
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Zoll Medical Corporation, an Asahi Kasei Group Company
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Nihon Kohden Corporation
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. ProgettiSrl
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Schiller AG
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. MS Westfalia GmbH
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. AMI Italia
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Bexen Cardio
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Silverline Meditech Pvt. Ltd.
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.11. Mediana Co., Ltd.
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
15.1.12. Shenzhen Mindray Bio-Medical Electronics
15.1.12.1. Overview
15.1.12.2. Product Portfolio
15.1.12.3. Profitability by Market Segments
15.1.12.4. Sales Footprint
15.1.12.5. Strategy Overview
15.1.12.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
External Defibrillators Market
